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Background: Testosterone deficiency is associated with increased serum cholesterol levels. However, how
testosterone deficiency precisely affects cholesterol metabolism remains unclear. Therefore, in the current study, we
examined the effect of testosterone deficiency on cholesterol metabolism and liver gene expression in pigs fed a
high-fat and high-cholesterol (HFC) diet.
Methods: Sexually mature male miniature pigs (6–7 months old) were randomly divided into 3 groups as follows:
intact male pigs fed an HFC diet (IM + HFC), castrated male pigs fed an HFC diet (CM + HFC), and castrated pigs
with testosterone replacement fed an HFC diet (CM + HFC + T). Serum testosterone levels and lipid profiles were
measured, and gene expression levels associated with hepatic cholesterol metabolism were determined.
Furthermore, total hepatic cholesterol contents and the activities of enzymes mediating hepatic cholesterol
metabolism were measured.
Results: Serum testosterone levels were significantly decreased in CM + HFC pigs, and testosterone replacement
attenuated castration-induced testosterone deficiency. Castration significantly increased the serum levels of total
cholesterol, low-density lipoprotein cholesterol and triglycerides, as well as hepatic lipid contents in pigs fed an HFC
diet. Compared with IM + HFC and CM + HFC + T pigs, low-density lipoprotein receptor (LDLR) mRNA expression
and protein levels were significantly decreased in the livers of CM + HFC pigs. In contrast, we found that compared
with IM + HFC pigs, hepatic proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA and serum PCSK9 protein
levels were significantly increased in CM + HFC pigs. Moreover, testosterone treatment reversed the increase in
PCSK9 expression in CM + HFC pigs. However, neither castration nor testosterone replacement affected the
expression of the other hepatic genes that were tested.
Conclusions: This study demonstrated that castration-induced testosterone deficiency caused severe hypercholesterolemia
in pigs fed an HFC diet; furthermore, these effects could be reversed by testosterone replacement therapy. Altered hepatic
PCSK9 and LDLR expression, resulting in reduced LDL-cholesterol clearance, may contribute to the increased serum
cholesterol levels induced by testosterone deficiency and an HFC diet. These results deepen our understanding of the
underlying molecular mechanisms that mediate the effects of testosterone deficiency on cholesterol metabolism.
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Aging in men causes a gradual decline in endogenous tes-
tosterone levels [1], which may have detrimental effects on
health status [2]. Numerous studies have shown that low
levels of endogenous testosterone are associated with an in-
creased risk of atherosclerosis in men [3-5], and serum
lipids are essential for atherosclerosis development [6,7].
Testosterone deficiency is thought to promote atheroscler-
osis by modulating lipid metabolism [8]. Several clinical
and epidemiological studies have reported that serum tes-
tosterone levels are inversely correlated with total choles-
terol and LDL cholesterol levels [9-11]. Moreover, animal
studies have also demonstrated markedly increased serum
cholesterol levels in testosterone-deficient male mice
[12,13]. These findings indicate that testosterone serves an
important role in regulating serum cholesterol metabolism.
However, to date the potential molecular mechanisms
whereby testosterone deficiency affects cholesterol metab-
olism are unclear.
The liver is a critical organ for normal cholesterol metab-
olism and contains numerous proteins and enzymes related
to cholesterol homoeostasis. Three well-studied examples
of such enzymes include 3-hydroxy-3-methylgutaryl coen-
zyme A reductase (HMGCR), which is the rate-limiting en-
zyme in cholesterol synthesis; the low-density lipoprotein
receptor (LDLR), which is responsible for the removal of
LDL-cholesterol from the blood; and cholesterol 7α-
hydroxylase (CYP7A1), which is the main enzyme respon-
sible for catalyzing the conversion of cholesterol into bile
acids and reverse cholesterol transport [14]. Furthermore,
sterol regulatory element-binding protein 2 (SREBP2) gov-
erns transcriptional activation of LDLR and HMGCR ,
whereas liver X receptor alpha (LXRα) regulates the tran-
scription of CYP7A1 [15]. To date, limited data are avail-
able regarding the effects of testosterone on the
modulation of hepatic cholesterol homeostasis-related pro-
teins. Therefore, it is unknown whether a testosterone
deficiency-induced increase in serum cholesterol levels is
related to changes in hepatic protein expression that are in-
volved in cholesterol metabolism.
Here, we aimed to determine the effect of testosterone
deficiency on cholesterol metabolism in pigs fed an HFC
diet. In additional, we explored potential associated
mechanisms by measuring the expression of genes re-
lated to hepatic cholesterol metabolism.
Methods
Animals and experimental procedures
All experimental procedures used in this study were ap-
proved by the Institutional Animal Care and Use
Committee of the Zhejiang Chinese Medical University
(Hangzhou, China). Eighteen sexually mature male Chinese
Wuzhishan (WZS) miniature pigs (6–7 months old) were
obtained from the Institute of Animal Sciences, HainanAcademy of Agricultural Sciences (Haikou, China). The an-
imals were housed in individual pens under environmental
conditions with a room temperature of 22°C ± 3°C, a rela-
tive humidity of 50% ± 20% and a 12-hour light/dark cycle.
The study protocol is outlined in Figure 1. The animals re-
ceived a standard diet without cholesterol during a 7-week
“pretreatment period” to facilitate acclimation to the envir-
onment and baseline determinations. At week 7, the pigs
were either surgically castrated or given a sham operation,
as described previously [16]. Testosterone was adminis-
trated weekly to castrated pigs via intramuscular injection
with testosterone propionate (10 mg/kg body weight;
Sigma-Aldrich, St. Louis, MO, USA) dissolved in corn oil
[17]. Testosterone replacement therapy was given on the
same day of castration to avoid the disruption of hormonal
influences. Pigs were fed an HFC diet starting from week 8
and were divided into 3 groups (n = 6 animals/group) as
follows: intact male pigs fed an HFC diet (IM +HFC), cas-
trated male pigs fed an HFC diet (CM + HFC), and cas-
trated pigs with testosterone replacement fed an HFC diet
(CM + HFC + T). The HFC diet used in this study was
comprised of 73% normal swine diet, 15% lard, 10% egg
yolk power, 1.5% cholesterol, and 0.5% sodium cholate. The
HFC diet was similar to an atherogenic diet, which has
been shown to induce hypercholesterolemia and athero-
sclerosis in pigs [18,19]. Body weights were recorded
weekly, and the study period was 12 weeks.
At the end of the experimental period, the animals were
sacrificed by exsanguination under anesthesia. The car-
casses were eviscerated as previously described [20], livers
were removed and weighed, and liver weight indexes were
calculated as liver weight/body weight ratios. Livers were
then frozen immediately in liquid nitrogen and stored at
−80°C for further analysis.
Analysis of serum parameters
Fasting blood samples were collected prior to castration
and twice weekly throughout the study. Sera were sepa-
rated from collected blood samples by centrifugation at
3000 × g at 4°C for 15 min and stored at −80°C for fur-
ther analysis. Serum testosterone concentrations were
measured at week 7 (0 w; the start of the experimental
period after the 7-week acclimation) and week 19 (12 w;
the end of the experimental period), using a commercial
radioimmunoassay kit (North Institute of Biological
Technology, Beijing, China).
Serum samples were analyzed to determine serum lipid
levels. Total cholesterol (TC), high-density lipoprotein
cholesterol (HDL-C), low-density lipoprotein cholesterol
(LDL-C), and total triglyceride (TG) were measured with
commercial kits (Rongsheng Biotech, Co., Ltd., Shanghai,
China) using an Automatic Biochemistry Analyzer
(Hitachi 7020, Tokyo, Japan). Serum PCSK9 was measured
using a commercial enzyme-linked immunoassay (ELISA)
Figure 1 Schematic representation of the experimental design. Sexually mature male miniature pigs (6–7 months old) were fed a standard
diet without cholesterol for 7 weeks. At week 7, the pigs were either surgically castrated or given a sham operation. Moreover, testosterone
replacement therapy was given on the day of castration. Beginning at week 8, intact male pigs (IM + HFC), castrated pigs (CM + HFC), and
castrated male pigs with testosterone replacement (CM + HFC + T) were fed the same high-fat and high cholesterol (HFC) diet for another
12 weeks, after which they were euthanized.
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cording to the manufacturer’s instructions.
Biochemical analysis in liver tissues
Liver samples were studied to determine the hepatic TC
and TG contents and enzyme activities. Hepatic lipids were
measured as described by Shi et al. [21] with slight modifi-
cations. Briefly, liver samples from each pig were homoge-
nized at 4°C in phosphate-buffered saline (pH 7.2). Liver
samples were then centrifuged at 3000 × g for 10 min at
4°C, and TC and TG levels in the resulting supernatants
were determined using commercially available kits
(Rongsheng Biotech, Co., Ltd., Shanghai, China), according
to the manufacturer’s instructions. Protein concentrations
in liver samples were measured with a BCA Assay Kit
(Pierce, Rockford, IL, USA).
Enzymatic HMGCR and CYP7A1 activities, as well as
LDLR concentrations, present in the livers were measured
using commercial ELISA kits (Biovol Biotech, Co., Ltd.,
Shanghai, China), as described previously [21].
Quantitative real-time PCR analyses
Total RNA from liver specimens was isolated using TRIzol
reagent (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. One microgram of total RNA
was reverse transcribed into cDNA using an MMLV-RT
Kit (Promega, Madison, WI, USA) according to the manu-
facturer’s protocol. Real-time PCR was performed using the
StepOnePlus Real-Time PCR Detection System (Applied
Biosystems, Inc., Foster City, CA, USA). The sequences of
primers used for measuring mRNA expression levels are
shown in Table 1. Amplifications were performed in 20-μL
reaction mixtures containing 10.4 μL of 2× SYBR Premix
Ex Taq (TaKaRa, Dalian, China), 0.4 μL of each primer(10 mM), 7.8 μL of distilled water, and 1.0 μL of cDNA.
The following thermocycling conditions were used for all
real-time PCR reactions: 95°C for 5 min, followed by 40 cy-
cles of 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s. After
amplification, melt curve analysis was performed to con-
firm the reaction specificities. All measurements were per-
formed in triplicate. β-Actin was used as a reference gene
to normalize gene expression. The 2-ΔΔCT method was used
to analyze the qRT-PCR data and assign relative expression
differences [22].
Statistical analysis
The results are presented as mean ± SEM. The data were
analyzed by one-way analysis of variance (ANOVA),
followed by Tukey’s test. Correlation analysis was per-
formed using Pearson’s test. P values of less than 0.05
were considered statistically significant. All statistical
analyses were performed by using SPSS software, version
13.0 (SPSS, Chicago, IL, USA).
Results
Body weight, liver weight, and serum testosterone levels
Body weight, liver weight, and serum testosterone levels
in pigs after 12 weeks of being fed an HFC diet are
shown in Table 2. Initial body weights were similar in
pigs in the IM + HFC, CM + HFC, and CM + HFC + T
groups. CM + HFC pigs fed an HFC diet gained less
weight than did pigs in the other groups. With testoster-
one replacement, the body weights of CM + HFC + T
pigs increased and were similar to the body weights of
pigs in the IM + HFC group (Table 2). Liver weight in-
dexes in CM + HFC pigs were higher than those in the
IM + HFC and CM + HFC + T groups, but these differ-
ences were not significant (P > 0.05).
Table 1 Primers used for quantitative real-time RT-PCR
Gene Primer sequences (5′-3′) Gen bank accession no.
LDLR Forward TCCAAGAGAAAGGCTCCAAG NM_001206354.2
Reversed CTCCGTCACCAGCGAGTAG
SREBP2 Forward GATGGGCAGCAGAGTTCC XM_005658510.1
Reversed ACAGCAGCAGGTCACAGGT
LXRα Forward AGATGTCCTTGTGGGTGGAG NM_001101814.1
Reversed CAGAGACTGGCTGCTTGC
HMGCR Forward ACAGAAGCGATGGTTGAGGT NM_001122988.1
Reversed AGATGGCAGTCACGATGTTG
CYP7A1 Forward GAATGACACCCTCTCCACCT NM_001005352.2
Reversed GGAATAAGCACCAGAAAGTCG
PCSK9 Forward GAACCTGGAGCGGATTCTC XM_003356453.2
Reversed CACTTTGGATGCTGGTGTCT
β-Actin Forward ACTGGGACGACATGGAGAAGA DQ178122
Reversed TTGGCTTTGGGGTTCAGG
LDLR, low-density lipoprotein receptor; SREBP2, sterol regulatory element binding protein 2; LXRα, liver X receptor alpha; HMGCR, 3-hydroxy-3-methylgutaryl
coenzyme A reductase; CYP7A1, cholesterol 7α-hydroxylase; PCSK9, proprotein convertase subtilisin/kexin type 9; β-Actin, beta-actin.
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between groups before the study began. As expected, castra-
tion caused a significant decrease in serum testosterone
levels. The concentration of serum testosterone at the end of
the study was significantly lower in CM+HFC pigs than in
IM+HFC pigs (P < 0.01). Testosterone treatment increased
serum testosterone levels in CM+HFC + T pigs (P < 0.01;
Table 2).
Serum lipid profiles
To analyze the effects of castration and testosterone
treatment on serum lipid profiles in HFC-fed pigs,
serum lipids were measured at 0, 4, 8, and 12 weeks
post castration (Figure 2). CM + HFC pigs had higher
TC levels than did IM + HFC and CM + HFC + T pigs
by the fourth week of HFC supplementation (P < 0.01;
Figure 2A). There were no significant differences inTable 2 Body weight, liver weight, and serum testosterone le
IM + HFC
Body weight (kg)
Initialb 12.76 ± 0.45
Finalc 25.15 ± 0.86
Serum T concentrations (ng/mL)
Initial 7.82 ± 0.49
Final 3.52 ± 0.24**
Liver weight (g) 483.82 ± 47.04
Liver weight index (%) 1.92 ± 0.17
Note: aData are presented as mean ± SEM; n = 6 pigs per group. **P <0.01 and ##P <
ANOVA (Tukey’s test). bInitial: week 7 (0 w; the start of the experimental period afte
period). T: testosterone.serum TC levels between IM + HFC and CM +HFC + T
pigs (P > 0.05). Serum LDL-C followed a pattern similar
to that of TC in all groups of pigs (Figure 2B). However,
testosterone deficiency caused by castration had no sig-
nificant influence on serum HDL-C levels in HFC-fed
pigs (Figure 2C). Serum TG levels in CM + HFC pigs
were higher than those in IM + HFC pigs at week 12
(P < 0.01) and those in CM +HFC + T pigs at weeks 4, 8,
and 12 (P < 0.05; Figure 2D).Hepatic lipid contents
As illustrated in Figure 3, hepatic cholesterol and trigly-
ceride contents were also significantly higher in CM +
HFC pigs than in IM + HFC pigs (Figure 3). Moreover,
testosterone treatment attenuated the increase in hepatic
lipid contents in CM +HFC pigs (Figure 3).vels in pigs fed a high-fat and high-cholesterol dieta
CM+ HFC CM +HFC + T
12.14 ± 0.35 12.45 ± 0.89
23.69 ± 0.64 26.22 ± 1.20
8.22 ± 0.56 8.78 ± 0.24
0.25 ± 0.01 4.43 ± 0.31##
524.72 ± 69.88 558.38 ± 27.95
2.20 ± 0.25 2.12 ± 0.39
0.01, significant differences compared to the CM + HFC group determined by
r the 7-week acclimation). cFinal: week 19 (12 w; the end of the experimental
Figure 2 Effects of castration and testosterone replacement on serum total cholesterol (A), LDL-cholesterol (B), HDL-cholesterol (C),
and triglyceride (D) levels in pigs fed a high-fat and high-cholesterol diet. Data are presented as mean ± SEM; n = 6 pigs per group.
*P < 0.05 and **P < 0.01, IM + HFC vs. CM + HFC group; #P < 0.05 and ##P < 0.01, CM + HFC + T vs. CM + HFC group. Significant differences were
determined by analysis of variance (ANOVA; Tukey’s test).
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cholesterol metabolism
To investigate the effects of testosterone on the expression
of genes controlling hepatic cholesterol metabolism, mRNA
expression levels of SREBP2, LXRα, HMGCR , LDLR ,
CYP7A1, and PCSK9 were studied by quantitative real-time
PCR (Figure 4). The results showed that castration and tes-
tosterone replacement did not affect hepatic expression of
SREBP2, LXRα, HMGCR, or CYP7A1 at the mRNA level
(Figure 4). However, castration markedly suppressed hepatic
LDLR expression in CM+HFC pigs with respect to IM +Figure 3 Effects of castration and testosterone replacement on hepat
(A) Hepatic cholesterol contents. (B) Hepatic triglyceride contents. Data are
Significant differences compared to the CM + HFC group determined by AHFC pigs and CM +HFC + T pigs (P < 0.05; Figure 4). In
contrast, castration-induced testosterone deficiency induced
a 4.3-fold increase in hepatic expression of PCSK9 mRNA.
Moreover, testosterone treatment restored increased expres-
sion of PCSK9 in CM+HFC pigs (P < 0.01; Figure 4).
Enzyme activities of HMGCR, LDLR, CYP7A1, and PCSK9
Hepatic HMGCR and CYP7A1 activities, LDLR concentra-
tions, and serum PCSK9 levels were measured, as shown in
Figure 5. Evidently, neither castration nor testosterone treat-
ment affected the activities of HMGCR or CYP7A1 in theic lipid contents in pigs fed a high-fat and high-cholesterol diet.
presented as mean ± SEM; n = 6 pigs per group. *P < 0.05, **P < 0.01.
NOVA (Tukey’s test).
Figure 4 Effects of castration and testosterone replacement on liver SREBP2 (A), LXRα (B), HMGCR (C), LDLR (D), CYP7A1 (E), and PCSK9
(F) mRNA expression in pigs fed a high-fat and high-cholesterol diet. SREBP2, sterol regulatory element binding protein 2; LXRα,
liver X receptor alpha; HMGCR, 3-hydroxy-3-methylgutaryl coenzyme A reductase; LDLR, low-density lipoprotein receptor; CYP7A1, cholesterol
7α-hydroxylase; PCSK9, proprotein convertase subtilisin/kexin type 9. Data are presented as mean ± SEM; n = 6 pigs per group. *P < 0.05,
significant differences compared to the CM + HFC group determined by ANOVA (Tukey’s test).
Figure 5 Effects of castration and testosterone replacement on hepatic HMGCR (A), CYP7A1 (B) activities, LDLR concentrations (C), and
serum PCSK9 levels (D) in pigs fed a high-fat and high-cholesterol diet. HMGCR, 3-hydroxy-3-methylgutaryl coenzyme A reductase; CYP7A1,
cholesterol 7α-hydroxylase; PCSK9, proprotein convertase subtilisin/kexin type 9. Data are presented as mean ± SEM; n = 6 pigs per group.
*P < 0.05, **P < 0.01. Significant differences compared to the CM + HFC group determined by ANOVA (Tukey’s test).
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terone deficiency significantly reduced hepatic LDLR protein
levels in CM+HFC pigs (P < 0.01). Moreover, testosterone
replacement reversed the reduction in hepatic LDLR levels
in CM + HFC pigs (P < 0.05; Figure 5C). Serum PCSK9
levels were significantly increased by castration in pigs
(P < 0.05), but this effect was reversed by testosterone
replacement (Figure 5D).
Correlations between serum PCSK9 levels and LDL-C and
TC levels
We next investigated the correlation between serum PCSK9
levels and LDL-C and TC levels in pigs fed an HFC diet. As
shown in Figure 6, serum levels of PCSK9 were positively
correlated with LDL-C (r = 0.620, P = 0.006) and TC (r =
0.489, P= 0.023).
Discussion
In this study, we investigated the effects of testosterone
levels on cholesterol metabolism in pigs fed an HFC diet.
Our data indicated that CM+HFC pigs gained less weight
than did pigs in the other groups. Testosterone deficiency
was associated with a loss of lean muscle mass [20,23],
which constitutes approximately 50% of the body mass in
pigs [24]. The reduced weight of CM +HFC pigs may be
attributable to the loss of skeletal muscle mass induced by
castration. Serum cholesterol (total cholesterol and LDL-
cholesterol) levels were significantly higher in CM +HFC
pigs than in IM + HFC pigs. However, testosterone re-
placement attenuated these effects in CM + HFC pigs,
suggesting that testosterone may play a protective role in
diet-induced hypercholesterolemia. To the best of ourFigure 6 Correlations between serum levels of PCSK9 and LDL-C or T
low-density lipoprotein cholesterol; TC, total cholesterol.knowledge, the present study is the first to demonstrate
that testosterone deficiency induced by castration aggra-
vates diet-induced hypercholesterolemia in a porcine
model. In previous studies, researchers have used rodent
models to evaluate the effects of testosterone on serum
cholesterol levels; however, the observed relationships be-
tween testosterone and serum cholesterol levels are incon-
clusive [13,25,26]. In addition, the process of lipoprotein
metabolism differs greatly between rodents and humans
[27]. Pigs may be more relevant to the study of cholesterol
metabolism because of their high degree of similarity with
humans in terms of lipid metabolism and cardiovascular
physiology [27-29], making them an attractive alternative
to rodents. Importantly, our previous study revealed that
castration-induced testosterone deficiency results in ele-
vated serum cholesterol levels in pigs fed a normal diet
[20], suggesting that pigs are suitable models for studying
the effects of sex hormones on cholesterol metabolism.
In addition to its effects on serum cholesterol levels, tes-
tosterone deficiency also caused a significant increase in
serum TG levels in CM +HFC pigs. TGs in the liver are
packaged into very low-density lipoproteins (VLDLs) and
exported to the circulation. Excessive production of TG-rich
VLDL (VLDL-TG) contributes to hypertriglyceridemia [30].
Many genes are involved in the assembly and secretion of
VLDL-TG, such as the microsomal triglyceride transfer pro-
tein (MTP) and apolipoprotein A-V (apoA-V) [31,32].
Previous studies showed that testosterone regulates hepatic
MTP expression in rats and mice [25,33]. ApoA-V was re-
cently identified as an important modulator of TG metabol-
ism and shown to lower plasma TG levels in both humans
and animals [31,34]. The results of recent studies haveC. PCSK9, proprotein convertase subtilisin/kexin type 9; LDL-C,
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Moreover, the treatment of HepG2 cells with insulin de-
creased apoA-V expression [34,35]. Testosterone deficiency
is associated with obesity and insulin resistance [36,37].
Thus, testosterone deficiency may affect serum TG levels by
altering the expression of genes involved in lipoprotein as-
sembly and secretion. The role of testosterone in regulating
TG levels was not the primary goal of our study; although
this topic will be investigated in future studies.
Little is known regarding the molecular mechanisms
underlying the effects of testosterone deficiency on choles-
terol metabolism. Cholesterol homeostasis is controlled by
coordinated changes in the expression of multiple genes in-
volved in cholesterol biosynthesis, uptake, and efflux [21]. It
was well known that LXRα plays a critical role in cholesterol
metabolism [7] and that LXRα expression increases choles-
terol efflux by regulating its target genes. CYP7A1 is one of
the most important target genes of LXRα and was identified
as the rate-limiting enzyme in bile acid-synthesis for choles-
terol elimination [15]. In the present study, we observed that
castration had no effect on the liver mRNA expression levels
of LXRα or CYP7A1 in pigs. These results suggested that
the increased cholesterol levels observed in CM+HFC pigs
may not have resulted from enhanced cholesterol efflux
through the LXRα-CYP7A1 pathway. HMGCR is the rate-
limiting enzyme mediating de novo cholesterol synthesis
[38]. Similarly, hepatic HMGCR activity and mRNA expres-
sion were not changed by castration and testosterone re-
placement. Thus, testosterone deficiency might not
influence the de novo synthesis of cholesterol in the livers of
CM +HFC pigs. It is well known that LDLR is a crucially
important modulator of plasma LDL-cholesterol levels in
humans and animals. Increased LDLR expression was
shown to result in reduced serum LDL-cholesterol levels
[21]. We found that LDLR mRNA expression and protein
levels were significantly decreased in the livers of CM+HFC
pigs, compared to IM+HFC and CM+HFC+T pigs. This
agreed with our findings that CM+HFC pigs showed a sig-
nificant increase in both serum LDL-cholesterol and TC
levels. Moreover, these findings suggest that one of the
mechanisms through which testosterone deficiency can in-
crease serum cholesterol levels in CM+HFC pigs is by de-
creasing LDLR expression, thus inhibiting the removal of
LDL-cholesterol from the circulation. In animals, hepatic
LDLR and HMGCR are transcriptionally regulated by
SREBP2 [15]. However, in the present study hepatic SREBP2
mRNA expression was not influenced by castration and tes-
tosterone replacement, suggesting that other mechanisms
may participate in the regulation of LDLR. Previous studies
demonstrated that hepatic LDLR mRNA transcription can
be suppressed by a high-cholesterol diet [39-41]. Moreover,
dietary cholesterol has been reported to increase hepatic TG
and cholesterol stores, which in turn suppresses hepatic
LDLR mRNA levels [42]. Thus, the reduced hepatic LDLRmRNA expression observed in CM+HFC pigs may have re-
sulted from an increase in hepatic lipid stores induced by
testosterone deficiency and an HFC diet. Recent studies have
demonstrated a central role of PCSK9 in the regulation of
cholesterol metabolism by enhancing the degradation of
hepatic LDLR, resulting in increased serum LDL-cholesterol
concentrations [43,44]. Moreover, results from previous
studies indicated that the hormonal and dietary regulation
of hepatic LDLR involves posttranscriptional regulation by
PCSK9 [45,46]. Of note, we observed that PCSK9 mRNA
expression in liver was significantly increased in CM+HFC
pigs compared to IM+HFC and CM+HFC +T pigs. This
observation suggested that reduced hepatic LDLR protein
levels following castration in CM+HFC pigs may occur via
increased PCSK9 expression. In agreement with our find-
ings, data from a recent study demonstrated a reduction in
hepatic LDLR levels and severe hypercholesterolemia in
PCSK9-transgenic pigs [29]. Taken together, our findings in-
dicate that testosterone deficiency can increase serum LDL-
cholesterol and total cholesterol levels by altering the expres-
sion of PCSK9 and LDLR, and might increase the risk of
atherosclerosis and cardiovascular disease.
This study has several limitations. Only a small set of
pigs were included in the study owing to practical issues
associated with obtaining the animals. Moreover, we did
not measure hepatic testosterone (T) and 17β-estradiol
(E2) concentrations. Although testosterone deficiency
can increase serum cholesterol levels in HFC-fed pigs, it
should be considered that testosterone may be partially
effective after being aromatized to estrogen [25]. The
direct effects of testosterone were not examined in this
study. In addition, we only examined the expression pat-
terns of several key genes involved in cholesterol metab-
olism. Studying a select few genes cannot rigorously
define the genomic mechanisms through which testos-
terone deficiency induces increased serum cholesterol
levels. High-throughput technologies might be needed to
assess castration-induced hepatic transcriptome changes
in HFC-fed pigs. These issues should be addressed in fu-
ture studies.
Conclusions
In conclusion, the present study demonstrated that
castration-induced testosterone deficiency caused a sig-
nificant increase in serum cholesterol levels in pigs fed
an HFC diet, and these effects were reversed by testos-
terone replacement. Importantly, testosterone deficiency
could induce PCSK9 expression and reduce LDLR ex-
pression in the livers of CM + HFC pigs. The findings
suggest that the increased serum cholesterol levels ob-
served in CM + HFC pigs may be attributed in part to
impaired LDL-cholesterol clearance. The precise mecha-
nisms regulating the hypercholesterolemic effects of tes-
tosterone deficiency await more detailed investigation.
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